Nucleic acid therapies: Towards cardiac-specific recombinant adeno-associated viruses (rAAVs) of human origin: Directed evolution and characterization of novel AAV variants isolated from human failing hearts in models with human relevance and relevance fo
| Institution | Universitätsklinikum Hamburg-Eppendorf (UKE) |
|---|---|
| Project leader | Arne Hansen |
| Site | Hamburg/Kiel/Lübeck |
| Project type | Innovation Cluster |
| Funding | € 206.542,00 |
| Begin | 01.01.2021 |
| End | 31.12.2025 |
| Partnerprojekte |
|
Förderkennzeichen
81X2710183
Projektnummer
1315